Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 5
2017 3
2018 4
2019 4
2020 5
2021 16
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
[Syphilis: what's new?].
Monsel G, Palich R, Caumes É. Monsel G, et al. Among authors: palich r. Rev Prat. 2018 Oct;68(8):881-885. Rev Prat. 2018. PMID: 30869456 French.
Current and Future Tools for Diagnosis of Kaposi's Sarcoma.
Dupin N, Jary A, Boussouar S, Syrykh C, Gandjbakhche A, Bergeret S, Palich R. Dupin N, et al. Among authors: palich r. Cancers (Basel). 2021 Nov 25;13(23):5927. doi: 10.3390/cancers13235927. Cancers (Basel). 2021. PMID: 34885035 Free PMC article. Review.
Household transmission of SARS-CoV-2 infection in the Paris/Ile-de-France area.
Katlama C, Dudoit Y, Huyard J, Blanc C, Soulié C, Schneider L, Faycal A, Lenclume L, Hamani N, Qatib N, Tubiana R, Seang S, Sellem B, Costagliola D, Palich R, Valantin MA, Assoumou L. Katlama C, et al. Among authors: palich r. Eur J Clin Microbiol Infect Dis. 2022 Jan 8:1-10. doi: 10.1007/s10096-021-04345-9. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2022. PMID: 34997388 Free PMC article.
Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital.
Paccoud O, Tubach F, Baptiste A, Bleibtreu A, Hajage D, Monsel G, Tebano G, Boutolleau D, Klement E, Godefroy N, Palich R, Itani O, Faiçal A, Valantin MA, Tubiana R, Burrel S, Calvez V, Caumes E, Marcelin AG, Pourcher V. Paccoud O, et al. Among authors: palich r. Clin Infect Dis. 2021 Dec 6;73(11):e4064-e4072. doi: 10.1093/cid/ciaa791. Clin Infect Dis. 2021. PMID: 32556143 Free PMC article.
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
Palich R, Allavena C, Peytavin G, Soulie C, Tubiana R, Weiss L, Montoya Ferrer A, Duvivier C, Bouchaud O, Bottero J, Durand A, Lê MP, Marcelin AG, Dudoit Y, Assoumou L, Katlama C; ETRAL QD study group. Palich R, et al. J Antimicrob Chemother. 2021 Jan 19;76(2):477-481. doi: 10.1093/jac/dkaa423. J Antimicrob Chemother. 2021. PMID: 33099638 Clinical Trial.
39 results